Agency Forms Undergoing Paperwork Reduction Act Review, 28834-28836 [2021-11351]
Download as PDF
<![CDATA[
28834
Federal Register / Vol. 86, No. 102 / Friday, May 28, 2021 / Notices
• Motion to Adjourn
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[FR Doc. 2021–11312 Filed 5–27–21; 8:45 am]
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 6820–95–P
[FR Doc. 2021–11379 Filed 5–27–21; 8:45 am]
David Coscia,
Agency Liaison Officer, Office of Presidential
& Congressional Agency Liaison Services,
General Services Administration.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC);
Correction
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP, STAC); Notice of
Charter Renewal
Notice is hereby given of a change in
the meeting of the Healthcare Infection
Control Practices Advisory Committee
(HICPAC); June 3, 2021, from 9 a.m. to
3 p.m., EDT in the original FRN.
The teleconference was published in
the Federal Register on April 9, 2021,
Volume 86, Number 67, page 18533.
The teleconference meeting is being
corrected to update the time and should
read as follows:
SUMMARY: In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by audio and
web conference lines (300 audio and
web conference lines are available).
Registration is required. To register for
this web conference, please go to:
www.cdc.gov/hicpac. All registered
participants will receive the meeting
link and instructions shortly before the
meeting.
DATES: The meeting will be held on June
3, 2021, from 12 p.m. to 3 p.m., EDT.
This meeting is open to the public.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, CDC, 1600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027, Telephone: (404) 498–
0730; Email: HICPAC@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
17:28 May 27, 2021
Jkt 253001
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of charter renewal.
This gives notice that under
Public Law 111–347 (the James Zadroga
9/11 Health and Compensation Act of
2010), as amended by Public Law 114–
113, and the Federal Advisory
Committee Act (Pub. L. 92–463) of
October 6, 1972, the World Trade Center
Health Program Scientific/Technical
Advisory Committee, the Centers for
Disease Control and Prevention,
Department of Health and Human
Services, has been renewed for a 2-year
period through May 12, 2023.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D.,
Designated Federal Officer, WTCHP
STAC, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
Department of Health and Human
Services, 1600 Clifton Road NE,
Mailstop R–12, Atlanta, GA 30329–
4027, Telephone: (513) 841–4515;
Email: TCarreonValencia@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–11378 Filed 5–27–21; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
[30Day–21–21CT]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
submitted the information collection
request titled ‘‘Requirement for Negative
Pre-Departure Covid–19 Test Result or
Documentation of Recovery From
Covid–19 for all Airline or other Aircraft
Passengers Arriving into the United
States from any Foreign Country’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on February 12, 2021 to obtain
comments from the public and affected
agencies. This collection accompanies a
CDC Order of the same name. CDC
received two comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
E:\FR\FM\28MYN1.SGM
28MYN1
Federal Register / Vol. 86, No. 102 / Friday, May 28, 2021 / Notices
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Requirement for Negative PreDeparture Covid–19 Test Result or
Documentation of Recovery From
Covid–19 for all Airline or other Aircraft
Passengers Arriving into the United
States from any Foreign Country (OMB
Control No. 0920–1318, Exp. 5/31/
2021)—Extension—National Center for
Emerging Zoonotic and Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
This information collection
accompanies the Notice and Order
named above. Pursuant to 42 CFR 71.20
and as set forth in greater detail below,
this Notice and Order prohibit the
introduction into the United States of
any airline passenger departing from the
any foreign country unless the
passenger:
(1) Has a negative pre-departure test
result for COVID–19 (Qualifying Test),
or (2) written or electronic
documentation of recovery from
COVID–19 in the form of a positive viral
test result and a letter from a licensed
health care provider or public health
official stating that the passenger has
been cleared for travel (Documentation
of Recovery).
The negative test must be a viral test
that was conducted on a specimen
collected during the three days
preceding the flight’s departure from a
foreign country. Passengers must retain
written or electronic documentation
reflecting the Qualifying Test, or
Documentation of Recovery, presented
to the airline and produce such
documentation upon request to any U.S.
government official or a cooperating
state or local public health authority.
VerDate Sep<11>2014
17:28 May 27, 2021
Jkt 253001
Pursuant to 42 CFR 71.31(b), the
Order constitutes a controlled free
pratique to any airline with an aircraft
arriving into the United States from any
foreign country. Pursuant to the
controlled free pratique, the airline must
comply with the following conditions in
order to receive permission for the
aircraft to enter and disembark
passengers in the United States:
• Airline or other aircraft operator
must verify that every passenger—two
years of age or older—onboard the
aircraft has attested to receiving a
negative Qualifying Test result or to
having recovered from COVID–19 after
previous SARS–CoV–2 infection, and
being cleared to travel by a licensed
health care provider or public health
official.
• Airline or other aircraft operator
must confirm that every passenger
onboard the aircraft has documentation
of a negative Qualifying Test result or
Documentation of Recovery from
COVID–19.
Certain exemptions and waivers do
apply, and are as follows:
• Crew members of airlines or other
aircraft operators, provided that they
follow industry standard protocols for
the prevention of COVID–19 as set forth
in relevant Safety Alerts for Operators
(SAFOs) issued by the Federal Aviation
Administration (FAA).
• Airlines or other aircraft operators
transporting passengers with COVID–19
pursuant to CDC authorization and in
accordance with CDC guidance.
• Federal law enforcement personnel
on official orders who are traveling for
the purpose of carrying out a law
enforcement function, provided they are
covered under an occupational health
and safety program in accordance with
CDC guidance. Those traveling for
training or other business purposes
remain subject to the requirements of
this Order.
• U.S. Department of Defense (DOD)
personnel, including military personnel
and civilian employees, dependents,
contractors (including whole aircraft
charter operators), and other U.S.
government employees when traveling
on DOD assets, provided that such
individuals are under competent
military or U.S. government travel
orders and observing DOD precautions
to prevent the transmission of COVID–
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
28835
19 as set forth in Force Protection
Guidance Supplement 14—Department
of Defense Guidance for Personnel
Traveling During the Coronavirus
Disease 2019 Pandemic (December 29,
2020) including its testing guidance.
• Individuals and organizations for
which the issuance of a humanitarian
exemption is necessary based on both;
(1) exigent circumstances where
emergency travel is required to preserve
health and safety (e.g., emergency
medical evacuations), and (2) where
pre-departure testing cannot be accessed
or completed before travel. Additional
conditions may be placed on those
granted such exemptions, including but
not limited to, observing precautions
during travel, providing consent to postarrival testing, and/or self-quarantine
after arrival in the United States, as may
be directed by federal, state, territorial,
tribal or local public health authorities
to reduce the risk of transmission or
spread.
CDC is also performing random
compliance checks to help ensure
documentation, such as test results,
meet the requirement of the Order and
may collect some contact information in
the event some public health follow up
action is needed at the time of arrival.
Additionally, some outbound air
passengers flying to foreign countries
may be denied entry to their destination
country and may not be able to get a
COVID–19 test before boarding a plane
back to the United States. CDC works
with airlines to receive passenger
contact information of these returned air
passengers in case public health follow
up is needed.
CDC requests approval for an
estimated 197,919,951 annual burden
hours. The estimated respondent cost is
$9,297,175,813. CDC anticipates certain
cost burdens to respondents and record
keepers due to the requirements. These
costs fall into the following categories:
Æ Traveler testing and ancillary costs:
$30,789,500,000.
Æ Traveler deferred travel costs:
$116,327,500.
Æ Airline staff costs for digitizing
attestations: $55,036,667.
Æ Airline costs to store attestations:
$3,350 to $2,925,000 a year depending
on size of airline and number of
travelers.
E:\FR\FM\28MYN1.SGM
28MYN1
28836
Federal Register / Vol. 86, No. 102 / Friday, May 28, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Type of respondent
Form name
Traveler (3rd Party Disclosure)
Attestation of a negative COVID–19 test/Documentation indicating clearance for travel by a licensed healthcare provider or public health official.
Attestation of a negative COVID–19 test/Documentation indicating clearance for travel by a licensed healthcare provider or public health official.
Request Exemption on Urgent Humanitarian Basis—(No
form).
Contact information collection for public health follow up—
(No form).
95,000,000
1
2
95,000,000
1
5/60
1,300
1
2
5,700
1
5/60
Contact information collection for public health follow up—
(No form).
Contact information collection for public health follow up—
(No form).
835
1
5/60
835
1
10/60
Airline Desk Agent ..................
Traveler ...................................
Traveler with non-compliant
test or documentation of recovery.
Returned Inadmissible Traveler.
Airline Representative .............
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–11351 Filed 5–27–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–0900]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Contact
Investigation Outcome Reporting Forms
to the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 8, 2021 to obtain
comments from the public and affected
agencies. CDC received one comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
VerDate Sep<11>2014
17:28 May 27, 2021
Jkt 253001
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Contact Investigation Outcome
Reporting Forms (OMB Control No.
0920–0900, Exp. 05/31/2021)—
Revision—National Center for Emerging
Zoonotic and Infectious Diseases
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
(NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC proposes to collect passengerlevel, epidemiologic, demographic, and
health status data from state/local
Health Departments and maritime
operators at the conclusion of contact
investigations of individuals believed to
have been exposed to a communicable
disease during travel. The information
requested by CDC would be obtained by
the health departments or maritime
operators while conducting the contact
investigation according to their
established policies and procedures,
and would be reported to CDC on a
voluntary basis. This information will
assist CDC in fulfilling its regulatory
responsibility to prevent the
importation of communicable diseases
from foreign countries (42 CFR part 71)
and interstate control of communicable
diseases in humans (42 CFR part 70).
CDC provides state and local health
departments and maritime conveyance
operators with information to notify and
contact individuals, and to further
investigate this exposure by contacting
others who may have been potentially
exposed to disease. However, there
currently is no standardized tool or form
to collect pertinent information
regarding the outcome of such
investigations.
To address the need to inform CDC of
additional actions that may be needed to
further protect public health based on
the outcome of the contact
investigations, CDC has developed
forms to assist health departments and
maritime conveyance operators in
reporting back to CDC. The forms are
specific to the nature of the
investigation; Tuberculosis (TB),
E:\FR\FM\28MYN1.SGM
28MYN1
]]>Agencies
[Federal Register Volume 86, Number 102 (Friday, May 28, 2021)]
[Notices]
[Pages 28834-28836]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11351]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-21CT]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) submitted the information
collection request titled ``Requirement for Negative Pre-Departure
Covid-19 Test Result or Documentation of Recovery From Covid-19 for all
Airline or other Aircraft Passengers Arriving into the United States
from any Foreign Country'' to the Office of Management and Budget (OMB)
for review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
February 12, 2021 to obtain comments from the public and affected
agencies. This collection accompanies a CDC Order of the same name. CDC
received two comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should
[[Page 28835]]
be sent within 30 days of publication of this notice to
www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function. Direct written
comments and/or suggestions regarding the items contained in this
notice to the Attention: CDC Desk Officer, Office of Management and
Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Requirement for Negative Pre-Departure Covid-19 Test Result or
Documentation of Recovery From Covid-19 for all Airline or other
Aircraft Passengers Arriving into the United States from any Foreign
Country (OMB Control No. 0920-1318, Exp. 5/31/2021)--Extension--
National Center for Emerging Zoonotic and Infectious Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
This information collection accompanies the Notice and Order named
above. Pursuant to 42 CFR 71.20 and as set forth in greater detail
below, this Notice and Order prohibit the introduction into the United
States of any airline passenger departing from the any foreign country
unless the passenger:
(1) Has a negative pre-departure test result for COVID-19
(Qualifying Test), or (2) written or electronic documentation of
recovery from COVID-19 in the form of a positive viral test result and
a letter from a licensed health care provider or public health official
stating that the passenger has been cleared for travel (Documentation
of Recovery).
The negative test must be a viral test that was conducted on a
specimen collected during the three days preceding the flight's
departure from a foreign country. Passengers must retain written or
electronic documentation reflecting the Qualifying Test, or
Documentation of Recovery, presented to the airline and produce such
documentation upon request to any U.S. government official or a
cooperating state or local public health authority.
Pursuant to 42 CFR 71.31(b), the Order constitutes a controlled
free pratique to any airline with an aircraft arriving into the United
States from any foreign country. Pursuant to the controlled free
pratique, the airline must comply with the following conditions in
order to receive permission for the aircraft to enter and disembark
passengers in the United States:
Airline or other aircraft operator must verify that every
passenger--two years of age or older--onboard the aircraft has attested
to receiving a negative Qualifying Test result or to having recovered
from COVID-19 after previous SARS-CoV-2 infection, and being cleared to
travel by a licensed health care provider or public health official.
Airline or other aircraft operator must confirm that every
passenger onboard the aircraft has documentation of a negative
Qualifying Test result or Documentation of Recovery from COVID-19.
Certain exemptions and waivers do apply, and are as follows:
Crew members of airlines or other aircraft operators,
provided that they follow industry standard protocols for the
prevention of COVID-19 as set forth in relevant Safety Alerts for
Operators (SAFOs) issued by the Federal Aviation Administration (FAA).
Airlines or other aircraft operators transporting
passengers with COVID-19 pursuant to CDC authorization and in
accordance with CDC guidance.
Federal law enforcement personnel on official orders who
are traveling for the purpose of carrying out a law enforcement
function, provided they are covered under an occupational health and
safety program in accordance with CDC guidance. Those traveling for
training or other business purposes remain subject to the requirements
of this Order.
U.S. Department of Defense (DOD) personnel, including
military personnel and civilian employees, dependents, contractors
(including whole aircraft charter operators), and other U.S. government
employees when traveling on DOD assets, provided that such individuals
are under competent military or U.S. government travel orders and
observing DOD precautions to prevent the transmission of COVID-19 as
set forth in Force Protection Guidance Supplement 14--Department of
Defense Guidance for Personnel Traveling During the Coronavirus Disease
2019 Pandemic (December 29, 2020) including its testing guidance.
Individuals and organizations for which the issuance of a
humanitarian exemption is necessary based on both; (1) exigent
circumstances where emergency travel is required to preserve health and
safety (e.g., emergency medical evacuations), and (2) where pre-
departure testing cannot be accessed or completed before travel.
Additional conditions may be placed on those granted such exemptions,
including but not limited to, observing precautions during travel,
providing consent to post-arrival testing, and/or self-quarantine after
arrival in the United States, as may be directed by federal, state,
territorial, tribal or local public health authorities to reduce the
risk of transmission or spread.
CDC is also performing random compliance checks to help ensure
documentation, such as test results, meet the requirement of the Order
and may collect some contact information in the event some public
health follow up action is needed at the time of arrival. Additionally,
some outbound air passengers flying to foreign countries may be denied
entry to their destination country and may not be able to get a COVID-
19 test before boarding a plane back to the United States. CDC works
with airlines to receive passenger contact information of these
returned air passengers in case public health follow up is needed.
CDC requests approval for an estimated 197,919,951 annual burden
hours. The estimated respondent cost is $9,297,175,813. CDC anticipates
certain cost burdens to respondents and record keepers due to the
requirements. These costs fall into the following categories:
[cir] Traveler testing and ancillary costs: $30,789,500,000.
[cir] Traveler deferred travel costs: $116,327,500.
[cir] Airline staff costs for digitizing attestations: $55,036,667.
[cir] Airline costs to store attestations: $3,350 to $2,925,000 a
year depending on size of airline and number of travelers.
[[Page 28836]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Traveler (3rd Party Disclosure).... Attestation of a negative 95,000,000 1 2
COVID-19 test/
Documentation indicating
clearance for travel by a
licensed healthcare
provider or public health
official.
Airline Desk Agent................. Attestation of a negative 95,000,000 1 5/60
COVID-19 test/
Documentation indicating
clearance for travel by a
licensed healthcare
provider or public health
official.
Traveler........................... Request Exemption on Urgent 1,300 1 2
Humanitarian Basis--(No
form).
Traveler with non-compliant test or Contact information 5,700 1 5/60
documentation of recovery. collection for public
health follow up--(No
form).
Returned Inadmissible Traveler..... Contact information 835 1 5/60
collection for public
health follow up--(No
form).
Airline Representative............. Contact information 835 1 10/60
collection for public
health follow up--(No
form).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-11351 Filed 5-27-21; 8:45 am]
BILLING CODE 4163-18-P
